Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?
The new drugs this company is developing could be worth a lot more than the present market value of its stock.
Mindfully Curated
The new drugs this company is developing could be worth a lot more than the present market value of its stock.
Nvidia’s recent pullback should soon be only a memory.
The S&P 500 might not provide the diversification you’re looking for.
Bloom Energy’s platform could benefit from artificial intelligence’s growing power demands. Is it a buy today?
Feel free to poach a few of the Oracle of Omaha’s picks. His track record speaks for itself.
Nike stock is suddenly popular with the hedge fund set. Is it a buy?
New York Community Bancorp has fallen on hard times and so has TD Bank. TD Bank will be a much better option for most investors.
Walmart continues to blow expectations out of the water and is showing no signs of slowing.
Knowing these two important rules could help you make one of the biggest decisions in retirement planning.
These stocks are up by between 60% and 124% over the last year, but they could still have plenty more room to run.
Buffett likes to bet big on his highest-conviction ideas.
Peloton stock soared on its latest earnings report. Can it keep gaining?
This exchange-traded fund only holds the top performing stocks from the S&P 500, and disregards the rest.
This longtime outperformer is set to conduct its sixth stock split since going public.
Hint: It has nothing to do with its upcoming earnings report.
Unfortunately, things aren’t looking too rosy in the context of next year’s raise.
Apple is trading on its past performance, not current fundamentals.
The Oracle of Omaha has overseen the purchase of close to $78 billion worth of his favorite stock since July 2018.